BiomX Inc. (PHGE) Financials
PHGE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 33.1 million | 24.9 million |
2023-06-30 | 41.3 million | 25.4 million |
2023-03-31 | 41.4 million | 25.3 million |
2022-12-31 | 45.5 million | 24.5 million |
PHGE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.0 million | 195000 |
2023-06-30 | -4.1 million | 271000 |
2023-03-31 | -5.1 million | 175000 |
2022-12-31 | -7.2 million | 367000 |
PHGE Net Income
No data available :(
PHGE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 22.5 million | - | 3.8 million |
2023-06-30 | 29.7 million | - | 4.1 million |
2023-03-31 | 29.3 million | - | 4.3 million |
2022-12-31 | 33.3 million | - | 4.5 million |
PHGE Shares Outstanding
PHGE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 32000 | 5.6 million | 2.2 million | - |
2023-06-30 | 1000 | 3.8 million | 2.3 million | - |
2023-03-31 | 10000 | 4.6 million | 1.6 million | - |
2022-12-31 | 32000 | 3.2 million | 2.0 million | - |
PHGE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | -89000 | 219000 |
2023-06-30 | -90000 | 217000 |
2023-03-31 | -91000 | 223000 |
2022-12-31 | -134000 | 624000 |
PHGE
Price: $0.40
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -0.37
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 145100
Market Capitalization: 17.3 million